Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.